Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiao Chu

Showing results (201-210 of 260) with videos related to

Pageof 26
Sort By:
Ebiomedicine|February 11, 2019
Fatty acid receptor GPR120 promotes breast cancer chemoresistance by upregulating ABC transporters expression and fatty acid synthesisXue Wang, Songbing He, Yuting Gu, et al.
Pharmacological Research|July 30, 2017
Terfenadine combined with epirubicin impedes the chemo-resistant human non-small cell lung cancer both in vitro and in vivo through EMT and Notch reversalLi An, Dan-Dan Li, Hai-Xiao Chu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 18, 2025
Nanobody-engineered bispecific IL-18 mimetics drive antitumor immunity by engaging CD8<sup>+</sup> T cell and evading IL-18BP in preclinical modelsYanyang Nan, Min Zhu, Qian Wang, et al.
Cancer Immunology, Immunotherapy : CII|March 19, 2025
Early local therapy in combination with PD-1/PD-L1 inhibitors in oligometastatic non-small cell lung cancer: results from a prospective multicenter observational studyJie Gao, Aihua Lan, Xi Yang, et al.
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Pattern of Recurrence Analysis in Metastatic EGFR-Mutant NSCLC Treated with Osimertinib: Implications for Consolidative Stereotactic Body Radiation TherapyTiantian Guo, Jianjiao Ni, Xi Yang, et al.
Plos Medicine|August 1, 2025
Consolidative stereotactic radiotherapy for oligo-residual non-small cell lung cancer after first-line chemoimmunotherapy: A single-arm, phase 2 trial from ChinaHongru Chen, Lu Yu, Fei Liang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 26, 2011
Multimodal therapy for adult Wilms' tumour: an experience from one centreJian-Jun Li, Hai-Hui Huang, Jian Shen, et al.
The Journal of Biological Chemistry|June 7, 2012
Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora diseaseErica Tiberia, Julie Turnbull, Tony Wang, et al.
Frontiers in Oncology|June 5, 2023
Primary pulmonary hyalinizing clear cell carcinoma with fusions of both EWSR1::CREM and IRF2::NTRK3: report of a case with an aggressive behaviorYou-Li Wu, Feng Wu, Mian-Fu Cao, et al.
Life Sciences|January 25, 2020
Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivoHong-Yuan Lu, Hai-Xiao Chu, Yu-Xin Tan, et al.
Pageof 26

Showing results (201-210 of 260) with videos related to

Sort By:
Pageof 26
Ebiomedicine|February 11, 2019
Fatty acid receptor GPR120 promotes breast cancer chemoresistance by upregulating ABC transporters expression and fatty acid synthesisXue Wang, Songbing He, Yuting Gu, et al.
Pharmacological Research|July 30, 2017
Terfenadine combined with epirubicin impedes the chemo-resistant human non-small cell lung cancer both in vitro and in vivo through EMT and Notch reversalLi An, Dan-Dan Li, Hai-Xiao Chu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 18, 2025
Nanobody-engineered bispecific IL-18 mimetics drive antitumor immunity by engaging CD8<sup>+</sup> T cell and evading IL-18BP in preclinical modelsYanyang Nan, Min Zhu, Qian Wang, et al.
Cancer Immunology, Immunotherapy : CII|March 19, 2025
Early local therapy in combination with PD-1/PD-L1 inhibitors in oligometastatic non-small cell lung cancer: results from a prospective multicenter observational studyJie Gao, Aihua Lan, Xi Yang, et al.
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Pattern of Recurrence Analysis in Metastatic EGFR-Mutant NSCLC Treated with Osimertinib: Implications for Consolidative Stereotactic Body Radiation TherapyTiantian Guo, Jianjiao Ni, Xi Yang, et al.
Plos Medicine|August 1, 2025
Consolidative stereotactic radiotherapy for oligo-residual non-small cell lung cancer after first-line chemoimmunotherapy: A single-arm, phase 2 trial from ChinaHongru Chen, Lu Yu, Fei Liang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 26, 2011
Multimodal therapy for adult Wilms' tumour: an experience from one centreJian-Jun Li, Hai-Hui Huang, Jian Shen, et al.
The Journal of Biological Chemistry|June 7, 2012
Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora diseaseErica Tiberia, Julie Turnbull, Tony Wang, et al.
Frontiers in Oncology|June 5, 2023
Primary pulmonary hyalinizing clear cell carcinoma with fusions of both EWSR1::CREM and IRF2::NTRK3: report of a case with an aggressive behaviorYou-Li Wu, Feng Wu, Mian-Fu Cao, et al.
Life Sciences|January 25, 2020
Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivoHong-Yuan Lu, Hai-Xiao Chu, Yu-Xin Tan, et al.
Pageof 26